Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Study of the Natural History of Two Autosomal Recessive Non Syndromic Deafness (DFNB1A and DFNB9) in Children up to 16 Years of Age

NCT05402813 is registered in ClinicalTrials.gov with Sensorion as lead sponsor.

NCT NCT05402813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05402813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Study of the Natural History of Two Autosomal Recessive Non Syndromic Deafness (DFNB1A and DFNB9) in Children up to 16 Years of Age
Lead sponsor
Sensorion
Phase
Observational
Overall status
Recruiting
Start date
November 18, 2022
Completion date
June 30, 2031
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aunb1, congenital deafness, dfnb1a, dfnb9, gjb2 gene mutation, otof gene mutation, sensorineural hearing loss, bilateral